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Abstract
Background: We employed DNA microarray technology to investigate the host response to
Streptococcus pneumoniae in a mouse model of asymptomatic carriage. Over a period of six weeks,
we profiled transcript abundance and complexity in the Nasal Associated Lymphoid Tissue (NALT)
to identify genes whose expression differed between pneumococcal-colonized and uncolonized
states.
Results: Colonization with S. pneumoniae altered the expression of hundreds of genes over the
course of the study, demonstrating that carriage is a dynamic process characterized by increased
expression of a set of early inflammatory responses, including induction of a Type I Interferon
response, and the production of several antimicrobial factors. Subsequent to this initial
inflammatory response, we observed increases in transcripts associated with T cell development
and activation, as well as wounding, basement membrane remodeling, and cell proliferation. Our
analysis suggests that microbial colonization induced expression of genes encoding components
critical for controlling JAK/STAT signaling, including stat1, stat2, socs3, and mapk1, as well as
induction of several Type I Interferon-inducible genes and other antimicrobial factors at the earliest
stages of colonization.
Conclusion: Examining multiple time points over six weeks of colonization demonstrated that
asymptomatic carriage stimulates a dynamic host response characterized by temporal waves with
distinct biological programs. Our data suggest that the usual response to the presence of the
pneumocccus is an initial controlled inflammatory response followed by activation of host
physiological processes such as response to wounding, basement membrane remodeling, and
increasing cellular numbers that ultimately allow the host to maintain an intact epithelium and
eventually mount a preventive adaptive immune response.
Background
Streptococcus pneumoniae, also known as the pneumococ-
cus, is a Gram positive, encapsulated bacterium recog-
nized as an important cause of pneumonia, meningitis
and sepsis throughout the world. Despite its nefarious
reputation, this organism usually establishes an obligate
asymptomatic association within the human nasopharyn-
geal cavity. This carrier state is of critical importance since
individuals asymptomatically colonized with S. pneumo-
niae serve as a reservoir for person to person transmission
of this organism, highlighting the significance of the
nasopharyngeal niche to pneumococcal survival within
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human populations. Asymptomatic pneumococcal colo-
nization of the upper respiratory tract is prevalent in most
human populations, with carriage rates exceeding 50% in
children ≤ 1 year [1]. While more common in children,
pneumococcal carriage in adults has been well docu-
mented [2]. Epidemiological evidence shows that the
duration of carriage in most individuals is transient, typi-
cally lasting 4–12 weeks [3,4].
The mechanisms underlying the establishment and clear-
ance of the pneumococcus from this niche are not well
understood. Recent studies have shown that asympto-
matic pneumococcal carriage induces localized mucosal
and systemic cellular immune responses in both rodents
and humans [5,6]. Subsequent clearance of the organism
is dependent upon the presence of CD4+ T cells at the
time of infection [7-9], suggesting a previously unrecog-
nized and important role for the cellular arm of the
immune response in the control of this pathogen.
The purpose of this study is to develop a picture of the
host response that occurs during establishment and reso-
lution of transient asymptomatic pneumococcal carriage
in the nasopharyngeal cavity. Insight into the events that
follow colonization may help us to better understand
how the host response to this mucosal surface interaction
develops. We performed a genome-wide transcriptional
analysis of the Nasopharyngeal Associated Lymphoid Tis-
sue (NALT) and overlying epithelial layer isolated from
infected and mock-infected mice over a six-week period.
Our analysis identified several hundred genes whose
expression was significantly changed in S. pneumoniae-col-
onized mice. Most notably, the host response to pneumo-
coccal carriage is characterized by innate immune
responses involving early induction of Type I Interferons
and Type I interferon-induced genes, hallmarks typically
associated with intracellular bacterial and viral infections.
These results suggest that these early innate responses may
play an as yet unappreciated role in controlling asympto-
matic mucosal colonization by S. pneumoniae.
Results
Pneumococcal colonization of the murine nasopharyngeal 
cavity
Pneumococcal colonization of the murine nasal cavity has
been previously demonstrated [10,11]. We colonized
BALB/c mice intranasally with 2 × 108 Type 2 pneumo-
cocci and monitored carriage over a six-week period. At
each time point, mice from both infected and mocked-
infected groups were sacrificed and NALT tissue was
excised as described [12]. NALT was chosen for host tran-
scriptional analysis because it is the functional homolog
of human tonsils and adenoids, which are thought to be
important local inductive and effector sites for both
mucosal and systemic responses to pneumococcal car-
riage [6,13,14]. The remainder of the head was homoge-
nized in PBS, which was then serially diluted and plated
to determine viable counts of the pneumococcus in the
nasopharyngeal cavity. Figure 1A shows the pneumococ-
cal load in the nasopharynx over a six-week period. Viable
counts decreased approximately three logs over a three
week period, and the bacteria were cleared by six-weeks
post infection, as we were unable to detect viable pneu-
mococci in the samples. In addition, fluorescence confo-
cal microscopy of nasal tissue allowed us to visualize
pneumococci at the NALT. Figure 1B shows a sagittal sec-
tion through the NALT isolated from a mouse that had
been inoculated with S. pneumoniae three days prior.
Using a fluorescently conjugated antibody directed
against the strain of S. pneumoniae used in these studies,
we detected bacteria on the surface of the NALT.
Gene expression patterns associated with pneumococcal 
colonization
We collected NALT samples from 3 infected and 3 mock-
infected mice at each of 5 time points during the course of
the experiment. Total RNA was isolated from these sam-
ples and was prepared for microarray analysis as described
in the Material and Methods section. We used two differ-
ent methods to identify genes whose patterns of expres-
sion distinguished infected and mock-infected samples.
The first method, Significance Analysis of Microarrays
(SAM) [15], identified genes whose expression consist-
ently differed between infected and mock-infected mice
over the entire time course. Of the 22,603 spots that met
or exceeded our cutoff threshold for high quality data, this
analysis identified 112 spots representing 87 genes (False
Discovery Rate = 5%) whose level of expression was sig-
nificantly associated with infection, and in 111/112 cases,
transcript levels were more abundant in the colonized ani-
mals (See Additional file 1: Table S1). Since we hypothe-
sized that carriage is a dynamic process, we were also
interested in identifying those genes whose expression
changes over the course of the infection. Thus, in a second
type of data analysis, we assessed the same list of 22,603
spots by quantifying the total amount of variation in
expression observed for each gene in both the infected
and mock-infected groups [16]. 7,163 spots were deter-
mined to show greater variance in the infected mice as
compared with the mock-infected controls. These spots
were ranked from most variable to least variable and we
considered the top 5% most variable data (358 spots) for
further analysis (see Additional file 2: Table S2).
Ontological analysis of the gene lists reveals several 
significant biological themes
The list of genes that distinguish infection from mock-
infection defined by the SAM and variation analyses were
further analyzed to identify biological themes associated
with them. To classify genes into categories, we employed
GeneTrail, a web-based software application that evalu-
ates gene lists for statistically significant enrichment ofBMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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biological processes when compared to the reference
input list [17,18]. To identify lexical enrichments, this
program uses terminology defined by the Gene Ontology
(GO) Consortium [19,20] and the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database [21,22]. The genes
listed in Table 1 were identified in the SAM analysis and
are associated with three GO categories: Mitosis/Cell Divi-
sion (p ≤ 0.003), Microtubule-based Process (p ≤ 0.035),
and Immune System Process (p ≤ 0.051). Table 2 lists the
processes that were enriched in the Variance gene list,
which includes the JAK/STAT Signaling Pathway (p  ≤
0.09), Basement Membrane (p  ≤ 0.04), Response to
Wounding (p ≤ 0.03), DNA Replication (p ≤ 0.03), and
Cell Division/Cell Cycle (p ≤ 0.02).
Dynamic changes in gene expression over the course of 
infection
Complementing these ontological analyses, we visualized
a union of both data sets, which is illustrated in Figure 2A.
Samples were arranged by time post-infection and genes
clustered using a Self Organizing Map (SOM) algorithm
[23]. Visualizing the data in this way graphically illustrates
the dynamic changes in gene expression during coloniza-
tion as compared with mock-infection. These patterns
roughly corresponded to gene subsets whose expression
was induced early in the time course (1–13 days), during
carriage (13–21 days), and at later stages when the organ-
isms were disappearing from the nasal cavity (21–42
days). We examined the genes associated with these tem-
poral categories to identify additional biological func-
tions potentially associated with colonization that weren't
revealed in the GeneTrail analyses. A set of 16 genes with
a marked increase in expression on Day 1 was characteris-
tic of early immune responses. 13 of the 16 genes are
known to be stimulated by a Type I Interferon Response.
A few of these genes were identified by both the SAM and
variance analyses (irg1, ifit3, and socs3). These 16 Early
Immune Response genes are listed in Table 3. We
extracted the data for these 16 genes, as well as all of the
genes in each of the GO or KEGG categories identified by
the GeneTrail analyses, and calculated an average expres-
sion value at each time point. These data were plotted to
give an average expression profile for each functional cat-
egory over the course of infection. Several of the catego-
ries, like Mitosis, Cell Division, Cell Cycle, Microtubule-
based Processes, and DNA Replication had similar expres-
sion profiles. Since these categories correspond to related
processes, they were combined into a single group. Figure
2B illustrates both the average gene expression profiles for
the major functional categories associated with carriage
and the heat maps of the individual members of these cat-
egories. We were thus able to map the temporal expres-
sion pattern of the biological themes associated with
asymptomatic colonization. Transcripts associated with
the Early Immune Response cluster were most abundant
between Days 1 and 6-post infection, after which their
abundance declined, whereas transcript abundance for
most of the genes involved in Cell Cycle and DNA Repli-
cation did not increase until Day 6 and continued
throughout the time course, with maximal differences
seen at Day 42. The genes comprising the Immune System
Process category showed more variability in the timing of
their induction but were, on average, most highly induced
midway through the time course. Alterations in the
expression profiles for the Basement Membrane and
Response to Wound Healing categories were more mod-
est, with initial changes seen during the first two weeks
followed by a return to baseline expression levels.
S. pneumoniae colonizes the nasopharynx of mice over a 6  week period Figure 1
S. pneumoniae colonizes the nasopharynx of mice 
over a 6 week period. (A) Viable cell counts from head 
cavities (post-NALT excision) of infected mice. Open circles 
represent viable counts from a single mouse. Solid lines rep-
resent the geometric mean of CFUs/head for each day. 
Dashed line represents the limit of detection. (B) Confocal 
immunofluorescence image of S. pneumoniae colonizing 
NALT tissue 3 days post-inoculation. The green bar bell indi-
cates the lumen of the nasopharynx, the pink bar bell indi-
cates the epithelial monolayer, and the blue bar bell indicates 
the cells within the NALT. S. pnuemoniae were visualized via 
fluorescently-conjugated antibody (green) near the surface of 
the NALT (blue) and were particularly apparent in the mucus 
layer (red).BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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Validating microarray data and demonstrating the 
induction of type I interferon genes during pneumococcal 
carriage
Of the several biological themes that emerged from the
ontology and visual analyses of the data, we were most
intrigued by the Early Immune Response category, as the
genes comprising this category are associated with an
inflammatory response. Given that our model is one of
colonization and not disease, we chose to focus primarily
on this category of genes. We validated the microarray
findings by quantifying irg1, ifit3, and socs3 transcripts via
quantitative reverse transcription PCR (qRT-PCR) using
several of the original RNA samples as templates. In addi-
tion to these samples, we also isolated new RNA samples
from the NALT of mice infected in an independent exper-
iment (seven mock-infected and five infected) and
assessed ifit3 transcript levels on Day 1 or Day 3 post-col-
onization. In all cases, we found that transcripts in the col-
onized mice were expressed at significantly higher levels
than in the mock-infected control mice (Figure 3A).
Since a number of the genes identified by microarray anal-
ysis were annotated as being "interferon-induced", we
wanted to determine which interferon(s) may participate
in the regulation of these genes. We selected 10 of the
RNA samples (five mock-infected and five infected) iso-
lated at Day 1 or Day 6 from the original experiment to
perform qRT-PCR for Type I (α and β) and Type 2 (γ)
interferons. We were unable to detect message for Type 2
interferons in these samples (data not shown), however,
we did observe that both α and β interferon transcript lev-
els were significantly higher in colonized animals com-
pared to the mock-infected control animals (Figure 3B)
suggesting that Type I Interferons were involved in the
induction of this set of genes.
Ply, a TLR4 ligand, is not required for induction of type I 
interferon induced genes during pneumococcal carriage
The induction of Type I Interferon genes is accomplished
by activation of a number of molecules that recognize
pathogen associated molecular patterns (PAMPs), includ-
ing members of the Toll-like receptor family (TLRs 3, 4, 7,
8, and 9), as well as intracellular receptors for viral RNA
(RIG-I and MDA5). There is evidence that S. pneumoniae
can activate TLR4 through pneumolysin (ply), a major vir-
ulence factor [24-27], and TLR9 [28,29]. TLR4 recognizes
ligands at the cell surface, while TLR9 is located predomi-
nantly in endosomal compartments. Since we are inter-
ested in the interactions that occur between a bacterium
and the mucosal surface during carriage, we wondered if
TLR4 was involved in inducing a Type I Interferon
response through its interactions with Ply. We infected
mice with WT (EJ1) and an isogenic ply- (EJ5) strain of
pneumococcus, isolated RNA at Days 1 and 3 from the
NALT. As type I IFN-inducible genes have a more robust
expression than type I IFN transcripts, we measured ifit3
transcript abundance as a downstream marker of Type I
Interferon induction in the same NALT RNA. As expected,
we observed a statistically significant difference in ifit3
transcript abundance between WT infected and mock
infected animals (Figure 3C). Of interest, while the ply-
infected animals did show a statistically significant
increase in ifit3  transcript as compared to the mock
infected animals, it was not as great as that of WT infected
animals, suggesting that Ply may contribute in part to
induction of Type I Interferons and downstream signal-
Table 1: Over-represented GO categories and the associated genes identified by GeneTrail from the SAM data.
Mitosis/Cell Division
(p ≤ 0.003)
Microtubule-based
Process (p ≤ 0.035)
Immune System Process
(p ≤ 0.051)
ccng1 cenpe flt3
cdc25c fbxo5 il1rl1
cdc45l nuf2 lilrb4
cdca5 tuba3a msh6
chek1 xrn2 pou2f2
fbxo5 ptpn22
nuf2 tacc3
sgol1 vav1
tipin vav2BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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ing. The difference in ifit3 transcript between WT and ply-
was not statistically different (p ≤ 0.18).
Discussion
General
A thorough understanding of the complex relationships
established between mucosal microorganisms and their
hosts has been difficult to achieve. These interactions
often occur without noticeable phenotype, which makes
it challenging to study in the laboratory. In addition, the
lack of any overt host response has led to the assumption
that these interactions are benign from an immunological
perspective, and have thus received little attention.
Here we present a comprehensive genome-wide view of
the host response to asymptomatic pneumococcal car-
riage demonstrating that it is a dynamic process character-
ized by increased expression of a set of early inflammatory
responses including induction of a Type I Interferon
response, and the production of several antimicrobial fac-
Table 2: Over-represented categories and the associated genes identified by GeneTrail from the variance data.
JAK/STAT
(p ≤ 0.09)
Basement Membrane
(p ≤ 0.04)
Response to Wounding
(p ≤ 0.03)
DNA Dependent DNA Replication
(p ≤ 0.03)
Cell Cycle/Cell Division
(p ≤ 0.02)
ccnd1 adamts cd55 gmnn bub1
il10ra col8a1 fn1 clspn ccnd1
stat1 entpd1 myh10 prim2 cdk8
stat2 lad1 reg3g mcm6 cdkn2a
nid2 f3 mcm7 clspn
entpd1 fert2
ccl24 gas1
gja1 gmmn
chi3l3 hells
darc mad2l1
mapk1
mcm6
mcm7
mki67
mphosph1
mtbp
nasp
ncapg2
sept6
syce2
tlk1BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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tors. These initial responses are down-regulated within the
first 2–3 weeks and are followed by increases in transcripts
associated with immune system processes that affect T cell
development and activation as well as those involved in
cell cycle control. These data suggest that nasal carriage of
S. pneumoniae results in an initial subclinical inflamma-
tion, which is insufficient to prevent colonization, fol-
lowed by other activities related to T cell activation,
wounding, basement membrane remodeling, and cell
proliferation. These subsequent physiological processes
presumably contribute to the resolution of pneumococcal
carriage in the nasopharynx. Our results are consistent
with recent studies suggesting that in contrast to "all or
nothing" responses, the immune system is constantly and
actively engaged in carefully calibrated responses to
microbial/mucosal interactions. This finely tuned and
complex spectrum of responses enables the host to strike
a balance between controlled inflammation to eliminate
potential pathogens and development of tolerance to the
normal microbial flora.
The early immune response in pneumococcal carriage
The up-regulation of many genes involved in early inflam-
matory responses upon pneumococcal colonization is
striking considering the absence of clinically obvious
symptoms. Of particular interest was the induction of
Type I Interferons and interferon-induced genes. The crit-
ical role that Type I interferons play in establishing an
antiviral state has been well documented over the last sev-
eral decades, and there is accumulating evidence suggest-
ing that these cytokines are also important in antibacterial
defense against intracellular bacterial infections [30-33].
However, there has been little data regarding the potential
role for Type I interferons in bacterial infections presumed
to be extracellular [34-36]. In mice, the majority of Type I
interferons are encoded by at least 14 interferon α-sub-
family genes and a single interferon β gene. We deter-
mined that Type I interferons are expressed at higher levels
in pneumococcal-colonized animals compared to the
mock-colonized control animals by qRTPCR using a
primer set specific for interferon beta and a set that ampli-
fies several members of the interferon alpha family (Fig-
ure 3B). Once secreted from the cell, Type I IFNs bind to
their cell surface receptor complex (INFAR) leading to the
activation of the JAK/STAT signaling pathway. This signal-
ing pathway in turn regulates the transcription of hun-
dreds of Interferon Stimulated Genes (ISGs), whose
products have anti-tumor, antiviral, immunomodulatory,
and pro-apoptotic activities. This complex program of cel-
lular responses permits affected cells to mobilize and
orchestrate the innate immune system to swiftly achieve a
state of resistance to intrusion by an infectious agent.
Genes encoding components critical for controlling JAK/
STAT signaling, including stat1, stat2, socs3, and mapk1
were identified in our microarray analyses as being
induced in the colonized, but not in the mock-infected
animals. Several ISGs were also found to be differentially
regulated in the colonized animals including oas1g, oas1l,
and oas2, casp4, ifit1, 2, and 3, gvin1, and ifi203. oas1g,
oas1l, and oas2 belong to a family of pro-apoptotic, inter-
feron-induced genes that are expressed in response to cell
injury and viral infection. casp4 is an interferon-induced
cysteine protease that has also been implicated in promot-
ing cellular apoptosis [37,38]. ifit1, ifit2 [39], ifit3 [40],
and ifi203 [41] are all IFN-a-inducible genes but have no
described function. Several families of Interferon-induced
GTPases have recently been described [42], and gvin1 is
the prototype member of the newest family of very large
IFN-inducible GTPases (VLIG) [43]. While the molecular
basis for the antimicrobial/antiviral properties has not
been elucidated for most of these GTPases, it is clear that
each family shows a surprising level of pathogen-specifi-
city in their activity [42].
In addition to the Interferon-induced genes, we also noted
the upregulation of other genes known to be involved in
Table 3: Terms associated with innate immune responses, 
particularly those involving type I interferons.
Early Immune Response
casp4
cd274
defb3
gvin1
ifi203
ifit1
ifit2
ifit3
irg1
oas1g
oas1l
oas2
s100a8
socs3
stat1
stat2BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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early host defense in the infected mice. s100A8 encodes
Calgranulin A, an intracellular calcium-binding protein
and a member of a large family of pro-inflammatory mol-
ecules that are induced upon tissue damage. S100A8 is
found in granulocytes, monocytes, and early differentia-
tion stages of macrophages [44-46]. Interestingly, S100A8
is also induced in keratinocytes and epithelial cells under
inflammatory conditions [47], and promotes neutrophil/
monocyte recruitment to inflamed tissues, which has
been documented during pneumococcal carriage [48].
Another host defense factor induced in our dataset is
murine β-Defensin 3 (defb3). β-Defensins are a family of
small cationic peptides produced predominantly by
NALT transcript analysis identifying genes that differentiate between mock-infected and pneumococcal-infected mice Figure 2
NALT transcript analysis identifying genes that differentiate between mock-infected and pneumococcal-
infected mice. Comparisons were made between infected samples and mock-infected controls using Statistical Analysis for 
Microarrays (SAM) and the Fligner-Killeen Test for equality of variance. These analyses identified 112 transcripts that consist-
ently differed during infection [SAM (FDR = 5%)] and the 358 transcripts (top 5%) that varied more during carriage as com-
pared to control mice. (A) A union of the gene sets was clustered using a self-organizing map algorithm; each row represents 
a single gene, and each column a single animal. Black indicates the median level of expression, red indicates greater expression 
than the median, green less expression, and gray missing data. Numerically labeled horizontal gray bars above the samples indi-
cate day post-colonization. (B) Expression profiles for the five functional categories identified. Heat maps illustrating the indi-
vidual genes comprising each category are shown. An average expression profile for each category was calculated and plotted 
to illustrate the temporal characteristics of each category. Purple: Early Immune Response; Green: Immune System Process; 
Orange: Response to Wounding; Blue: Basement Membrane; Yellow: Cell Cycle/DNA Replication.BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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Patterns of transcript abundance assessed by quantitative real time RT PCR as a function of pneumococcal colonization Figure 3
Patterns of transcript abundance assessed by quantitative real time RT PCR as a function of pneumococcal 
colonization. Validating the microarray data. Transcript abundance of (A) irg1, socs3, and ifit3 and (B) infa and infB was meas-
ured in mock infected and colonized mice using the original NALT RNA samples utilized for microarray analysis. These samples 
were collected from NALTs harvested within the first week of colonization. A second infection was established and RNA was 
isolated from NALTs of mock infected and pneumococcal colonized animals. Transcript abundance of ifit3 was measured in 
these samples (Ifit3*) (PANEL A). (C) A third infection time course was performed using mock infected, EJ1 (WT) colonized, 
and EJ5 (ply-) colonized mice. NALTs were isolated and the abundance of ifit3 transcript was assessed to determine to effect of 
pneumolysin on the Type I Interferon Response within the first week of colonization. Samples isolated on Days 1 and 3 post-
colonization were not statistically different from each other using any of the primer sets. Therefore, they were combined into 
a single group. Open circles represent mock infected samples, closed gray circles represent EJ1 colonized samples, and black 
circles represent EJ5 colonized samples. Horizontal lines represent the geometric mean. p values were calculated using a 1-
tailed Students T-test.BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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mucosal epithelial cells lining the respiratory, gastrointes-
tinal and genitourinary tracts. When these cells sense
microbial incursions, defensin peptides are released into
the mucosal environment where they bind to and disrupt
the cell membrane of microbes causing cell death. In addi-
tion to antmicrobial activity, many defensins also partici-
pate in cell signaling functions [49]. Bouskra et al report
on some very interesting work involving a connection
between murine β-Defensin 3 and the development of
intestinal lymphoid tissue [50]. These authors demon-
strate that genesis of isolated lymphoid follicles (ILFs) in
the intestine is absolutely dependent upon the presence of
the normal bacterial flora, and that the critical contribu-
tion of the microbiome in this process involves activation
of CCR6 signaling by murine β-Defensin 3. Mice lacking
either Defb3 or CCR6 are unable to form ILFs and as a
consequence, they observe 100-fold increases in the total
bacterial population in the intestine. These data suggest a
major role for ILFs in maintaining intestinal homeostasis
and demonstrate that normal intestinal flora and the
immune system communicate through an innate detec-
tion system that includes β-Defensin 3 to generate adap-
tive lymphoid tissues. These observations are of great
interest to us because, like the intestinal environment, the
nasopharyngeal niche contains secondary lymphoid folli-
cles within the NALT, which develop subsequent to
microbial exposure [51]. The observation that defb3  is
strongly induced at Day 1 in mice colonized with pneu-
mococcus may be an early marker of lymphoid follicle
formation in the NALT and may suggest an important role
for β-Defensin 3 in promoting a specific adaptive immune
response that ultimately helps to control the growth of S.
pneumoniae in this niche.
Expression of cd274 (also known as pd-l1 or b7-h1) was
also up-regulated in infected mice in the early time period.
This gene encodes a ligand that, in combination with its
receptor PD-1, delivers inhibitory signals that modulate
the activation state of monocytes and CD4+ T cells [52]
and is highly expressed on exhausted T cells during
chronic viral infections [53]. An intriguing possibility to
be further investigated is that PD-1 may be important for
determining the balance between T cell activation, toler-
ance, and pathology during Streptococcal carriage.
Induction of type I interferon response is not dependent 
upon the presence of pneumolysin, a TLR4 agonist
The induction of a Type I Interferon response in S. pneu-
moniae  in the context of invasive disease has been
described. Weigent et al [54] studied the role of interfer-
ons during interperitoneal (IP) pneumococcal infection.
They showed that antibody depletion of Interferon α and
β in mice resulted in marked decrease in survival after
infection with the pneumococcus. As a corollary to this
experiment, they also injected interferon α/β prior to
infection and showed that this provided substantial pro-
tection against pneumococcal challenge. In mouse mod-
els of sepsis and meningitis, Mancuso et al [55]
demonstrated that mice lacking the Type I Interferon
receptor were more likely to suffer more severe bacteremia
and die of infection that their WT counterparts. Our
results show that these chemokines are involved not only
in the response to invasive pneumococcal disease, but are
also induced at the earliest stages in carriage. We were
interested in determining the upstream signaling path-
way(s) involved in induction of Type I interferons during
pneumococcal carriage and focused on TLR4-mediated
induction since it is known that pneumococcus activates
TLR4 via the Ply hemolysin. Our results suggest that while
Ply is not absolutely required for induction of a Type I
interferon response, it may contribute to the magnitude of
that response (Figure 3C) during carriage. There is other
evidence to support such a role for Ply in Type I Interferon
signaling. Rogers et al examined the effects of S. pneumo-
niae and an isogenic ply- deletion strain on the gene expres-
sion of the THP-1 monocytic cell line [56]. THP-1 cells
exposed to the WT but not the ply- were able to induce
expression of one of the Type I Interferon Receptor subu-
nits (IFNAR2).
Immune system process GO category
As the expression of the genes defining the early response
to carriage decreased, we observed a concomitant and
marked increase in transcript abundance of several genes,
beginning on average at 3 weeks post-inoculation, that fell
into the Immune System Process GO category (Figure 2B).
Included in this category are ptpn22, lilrb4, il1rl1, vav1,
vav2, and flt3 – all of which are involved in T cell develop-
ment and/or activation and several of them contribute to
reducing excessive inflammation [57-60]. T cells, in par-
ticular CD4+ T cells, have recently been reported by several
groups to play a critical role in resolving pneumococcal
infection at both mucosal and systemic sites [8,9] and
may be the major mechanism involved in naturally occur-
ring, as opposed to vaccine-mediated, immunity to the
pneumococcus [7].
Response to wounding and basement membrane and DNA 
replication, cell division, and cell cycle GO categories
Genes within the Response to Wounding and Basement
Membrane categories (Table 2) were modestly dysregu-
lated in mice colonized with S. pneumoniae. Of particular
interest was the identification of ccl24 (eotaxin-2), entpd1,
and darc. Eotaxins (eotaxin-1 and eotaxin-2) have been
identified as highly potent and selective chemoattractants
for eosinophils in both mouse and humans [61-63].
While these proteins are redundant in function, it appears
that eotaxin-1 plays a role in the early recruitment of eosi-
nophils, while eotaxin-2 appears to be involved in eosi-
nophil infiltration at later time points [64]. entpd1, whichBMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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encodes an ecto-nucleoside triphosphate diphosphohy-
drolase 1 (also referred to as CD39) is a critical enzyme for
hydrolysis of released ATP into adenosine. This activity
has been shown to play a critical role in regulating neu-
trophil chemotaxis and cell migration [65]. darc, which
encodes the Duffy antigen receptor for chemokines has
been shown to bind inflammatory chemokines, however
until recently, its in vivo function was unclear. Recently,
Pruenster et al [66] demonstrated that DARC internalized
chemokines mediating chemokine transcytosis, leading to
apical retention of intact chemokines. This resulted in
increased leukocyte migration across monolayers express-
ing DARC and enhanced chemokine-induced leukocyte
extravasation in mice overexpressing DARC on blood ves-
sel endothelia. Taken together, our data may indicate a
role for chemotaxis of leukocytes and granulocytes, such
as neutrophils and eosinophils, in the host responses to
pneumococcal carriage.
The DNA Replication, Mitosis, Cell Division, Microtu-
bule-based Process, and Cell Cycle GO categories pertain
to processes involved in increasing cellular numbers
(Tables 1 and 2). In almost every case, the genes that make
up these categories are upregulated in infected mice begin-
ning on Day 6 and show maximal expression at the end of
the time course. These data imply that there is either an
increase in proliferating cells in the NALT in response to
the presence of the pneumococcus or an increase in cellu-
lar migration to the NALT. Definitive identification of cell
types associated with the GO categories will require addi-
tional studies. However, our data do lend support to the
idea that de novo proliferation of cells is occurring in the
NALT, at least to some extent; at Day 6, we observed an
increase in abundance of mki67  transcript.  mki67  is
expressed in actively cycling or recently divided cells but
not resting cells [67-69]. In the absence of histological
data on the cellular composition of NALT, we have
attempted to address this important issue of de novo repli-
cation vs cell migration by comparing the expression pro-
files of our samples with published gene sets derived from
distinct mouse tissues [70], which provide evidence corre-
lating particular cellular compositions with expression
data. The set of transcripts that increased in abundance in
infected NALT samples between Days 6 and 13 (Figure 2)
was enriched for genes associated with CD4+ T cells (p ≤
0.07). By Day 42, the association with lymphoid cells was
both more significant and more generalized, with expres-
sion of genes associated with CD4+ T cells, CD8+ T cells,
and thymus tissue significantly correlated with the pat-
terns of gene expression we observed (p ≤ 0.02, 0.02, and
0.01, respectively). Messages encoding immunoglobulin
heavy chain subunits (Igh-1a and Igh-VJ558) were also
more abundant at this time point and there was a highly
significant overlap with a set of transcripts that were abun-
dant in germinal center B cells following antigen-specific
activation within the lymphoid tissue (p ≤ 4E-6) [71].
Gene expression programs associated with activation or
proliferation of specific cell types were also evident in our
transcript data and Gene Ontologies. For example, tran-
scripts more abundant at Day 13 in infected animals were
associated with activation of murine macrophages in
response to LPS and/or IFNγ but not the TH2 cytokine IL4
(p ≤ 8E-6) [72], which may signify an important role for
this cell type in the response to pneumococcal coloniza-
tion. In addition, the identification of expression patterns
associated with T cells and proliferation in our data is con-
sistent with a recent report that examined histology and T
cell proliferation in the NALT of mice infected with Group
A Streptococcus (GAS) [73]. The authors report that GAS
antigen-specific T cell priming, followed by a robust pro-
liferation of T cells, occurred in the NALT within 4 days
post-colonization. Re-challenge of these same mice with
GAS drives the differentiation of effector T cells that
express primarily T helper 1 (Th1) pro-inflammatory
cytokines. Taken together, our observations and analysis
prompt us to speculate that an early IFN-driven innate
host response may lead to a TH1-type adaptive immune
response. The presence of proliferation-associated tran-
scripts as long as 6 weeks after infection in our dataset sug-
gests that detailed histological and functional studies may
reveal sustained alterations in the local immune environ-
ment that influence the response to subsequent infection
with Streptococcus or other microbial agents.
It is important to recognize that our findings are based on
examination of a single bacterial serotype colonizing a
single mouse strain. We acknowledge that some of the
host responses we observe in our study may be serotype-
specific, but we believe that the vast majority of the
responses will be elicited in a serotype-independent man-
ner. Several lines of evidence indicate that factors other
than capsule play a critical role in the development of the
host response to pneumococci. For instance, in 1–2 year
olds, the incidence of pneumococcal disease and
nasopharyngeal colonization caused by different sero-
types decreases sharply and simultaneously, suggesting
that the host initiates a response that concurrently targets
several different serotypes rather than mounting many
individual immune responses that are serotype-specific.
Secondly, experimental human carriage studies demon-
strate that clearance of the colonizing strain is not tempo-
rally associated with the development of serotype-specific
immunity [5,10]. Thirdly, several groups have now con-
firmed the critical involvement of cellular immunity
(CD4+ T cells) in the clearance of pneumococcal carriage
[7-9]. Since capsular polysaccharide is generally consid-
ered to be a T cell-independent antigen, there must beBMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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other serotype-independent bacterial factors that are
important for host recognition of, response to, and clear-
ance of the pneumococcus that are shared among many if
not all colonizing S. pneumoniae isolates.
The enrichment of these 5 major functional categories in
the infected animals provides a picture in which the
nasopharyngeal tissue responds to the presences of pneu-
mococci, and presumably other infection agents, with a
closely regulated and specific arm of the inflammatory
response that includes anti-microbial peptides. This proc-
ess is undoubtedly an attempt to preserve and sustain an
intact epithelial barrier.
For much of the past century, research on the pneumococ-
cus has focused on understanding how this organism
causes overt disease and elucidating the bacterial factors
involved in this process. Our understanding of the host/
microbe relationship has become more nuanced over
time; we now appreciate that most of these interactions do
not result in disease, and even those that do often do so
only in certain hosts, highlighting that the outcome of a
microbial/host interaction – that of disease or health –
cannot be perfectly predicted simply by the initiation of
that interaction. Rather, the consequences of these associ-
ations are determined by a complex and dynamic series of
interactions. Furthermore, emphasis on disease neglects
an important biological facet of the pneumococcal/host
relationship: the human nasopharynx is the only known
reservoir for this organism. Given that this bacterial/host
interaction is essential for maintaining S. pneumoniae in
human populations, refocusing some of our attention on
the most frequent outcome of colonization, that of
asymptomatic carriage of the mucosal surface, will likely
lead to a better understanding of how this microbe inter-
acts with its host.
Since carriage causes no obvious clinical symptoms, deter-
mining its actual impact on the biology of an animal has
been difficult to ascertain. Nevertheless, there has been
recent interest in dissecting the relationship established
during carriage from both the bacterial as well as the host
perspective. Several groups have conducted studies that
examine the bacterial response to pneumococcal coloni-
zation in vitro and in vivo [9,74-81]. Studying the host
response to carriage is more challenging because mode-
ling the human host nasopharyngeal niche in vitro or in
vivo is difficult. A few groups have conducted experiments
examining the effects of S. pneumoniae cultures or culture
extracts on explants of human nasopharyngeal and ade-
noid tissues in culture [82-84]. However, the fragile
nature of the tissue samples necessitated very limited
exposure time to S. pneumoniae and/or its products and
focused predominantly on the bacterial impact on ciliary
beat frequencies and epithelial cell integrity. Other studies
have utilized mouse models to determine the contribu-
tion that particular host factors have on colonization and
how they impact carriage by measuring serum antibody
levels to pneumococcal antigens and assessing the ability
of different mouse mutants to clear the pneumococcus
from the nasopharynx [7,9,10,85]. These types of studies
have contributed valuable insight regarding specific host
proteins involved in pneumococcal carriage, but they
reveal only a limited dimension of the host response to
carriage. The development of genomic tools, such as
microarray technology, has facilitated a global examina-
tion of this process. Microarry technology allows for the
simultaneous examination of the transcriptional profile
for every gene in a genome, and is particularly well suited
to identify genes for which the impact of a specific process
or condition, such as asymptomatic carriage, is unknown.
Nelson et al [86] performed a microarray-based analysis
on mice asymptomatically infected with S. pneumoniae
and examined differences in gene expression in the epi-
thelium overlying the turbinates between colonized and
mock-colonized animals at a single time point, three days
post-inoculation. In doing so, they identified one gene
that differentiated pneumococcal-colonized animals from
non-colonized animals.
The strength of our study lies in the examination of mul-
tiple time points over a six week period. This allowed us
to investigate not only the earliest interactions between
microbe and host, but also the changes that occur in the
host while the organism is being carried subsequent to its
clearance by the immune system, revealing the dynamic
nature of the carrier state.
Conclusion
This study provides a more subtle view of the host/
microbe relationship as compared with the usual over-
whelming systemic infection achieved in the laboratory
by direct inoculation of the pneumococcus beyond the
epithelial barrier. Our data suggest that the usual response
to the presence of the pneumocccus in the nasopharynx is
a controlled inflammatory response involving Type I
Interferon signaling and appears to involve host physio-
logical processes such as response to wounding, basement
membrane remodeling, and increasing cellular numbers
to maintain an intact epithelium and eventually a preven-
tive adaptive immune response.
Methods
Bacteria and growth conditions
EJ1, a streptomycin-resistant derivative of D39 serotype 2,
and EJ5, a streptomycin and spectinomycin-resistant EJ1
derivative deleted for pneumolysin (ply-) [87], were used
in this study. Both strains were grown in brain heart infu-
sion (BHI) broth (Difco), and on tryptic soy agar (TSA;
Difco) supplemented with 5% defibrinated sheep bloodBMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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(Hemostat Laboratories, Dixon, Calif.) at 37°C in 5–10%
CO2. Both broth and agar media were supplemented with
streptomycin (200 μg/ml) and/or spectinomycin (200 μg/
ml) as needed. Agar medium also contained oxolinic acid
(5 μg/ml) and colistin (10 μg/ml).
Infection of mouse nasopharyngeal cavity, isolation of 
NALT, and plating viable counts
10–12 week old female BALB/c mice (Jackson Laborato-
ries, Bar Harbor, Maine) were used during this study and
were housed and cared for in accordance with Stanford
University's Administrative Panel on Laboratory Animal
Care (APLAC) protocols. To establish carriage, streptococ-
cal strains were grown to an OD600 = 0.4, corresponding to
a density of 1 × 108 CFU/ml. Cultures were centrifuged at
7,500 g for 10 min at 4°C. Cells were washed once in ster-
ile phosphate buffered saline (PBS) and resuspended in
PBS to a density of ~2 × 1010 CFU/ml. Mice were lightly
anaesthetized by exposing them for ~20 seconds to an Iso-
fluorane-saturated cotton ball in a closed container. For
the original time course experiment, mice were inoculated
intranasally with either 10 μl of the above bacterial sus-
pension (2 × 108 CFUs) (n = 15) or 10 μl PBS (n = 15). At
1, 6, 13, 21, and 42 days post inoculation, 3 mice from
each group were sacrificed by CO2 asphyxiation and the
nasal associated lymphoid tissue (NALT) was excised as
described [12]. In brief, the skin and mandible were
removed from each mouse head. Mice were pinned to a
board face up and a dissecting scope was used for palate
removal. The hard palate was excised using a #11 scalpel
(Feather Disposable). Forcepts were used to carefully pull
back the palate, exposing the underlying bilateral lobes of
NALT. This tissue, which included the NALT, the overlying
epithelial layer, and the hard palate was placed in a cryo-
vial and flash frozen in liquid nitrogen. Samples were
stored at -80°C. Subsequent to NALT excision, the central
incisors were removed with a razor and a coronal section
was cut through the skull at the tympanic bulla to remove
the brain. The remainder of the head was homogenized in
PBS and plated to determine bacteria load in the infected
mice. Carriage was not accompanied by bacteremia as
determined by plating blood samples obtained by cardiac
puncture for viable counts. Similar methods were used for
follow up experiments except that mice were sacrificed at
Days 1 and 3 post-establishment of carriage.
RNA preparation
Total RNA was isolated from the NALT samples using the
MELT Kit (Catalog # AM1983) following the manufactur-
ers recommendations (Applied Biosystems/Ambion, Aus-
tin, TX). Each RNA sample was subjected to spectroscopy
and gel analysis. RNAs determined to be of high purity
(260/280 ~1.8) and intact by gel analysis were used for
microarray analysis (n = 28) or quantitative real time RT
PCR.
Microarray hybridization
Sample RNA transcripts and a standard reference RNA
(Universal Mouse Reference RNA, Stratagene, La Jolla,
CA) were amplified using the MessageAmp aRNA amplifi-
cation kit (Ambion, Austin, TX) in the presence of amino
allyl-labeled dUTP. Cy5 dye was subsequently conjugated
to the experimental sample aRNAs, while Cy3 dye was
conjugated to the reference aRNA. Equivalent amounts of
sample and reference aRNAs were combined and hybrid-
ized to the Mouse Exonic Evidence Based Oligonucleotide
(MEEBO) array [88]. Arrays were washed and then
scanned using a GenePix 4000A scanner (Axon Instru-
ments, Foster City, Calif.), and images were analyzed with
GenePix Pro software. The raw data were loaded into the
Stanford Microarray database [89]. The data are publicly
available both in the Stanford Microarray Database and in
the NIH Gene Expression Omnibus [90].
Microarray data filtering and analysis
Data were filtered to include only spots that met the fol-
lowing criteria for at least 80% of the samples tested: sig-
nal intensity 2.5-fold above background in either the Cy5
(sample) or Cy3 (reference) channel, and a regression cor-
relation for the two channels of at least 0.6 across each
measured element. A normalization factor was applied so
that the mean log2 ratio for each array (sample) was zero,
and data for each spot were then median-centered across
all observations. Transcripts that differed in abundance in
control and infected mice were identified using Signifi-
cance Analysis of Microarrays [15]; control and infected
samples from each time point were treated as matched
pairs. The Fligner-Killeen test for equality of variance [16]
was used to identify transcripts with more variable expres-
sion in the infected mice than the control mice. Selected
data from infected samples were normalized to the aver-
age of the day-matched control samples, organized using
a Self Organizing Map (SOM) algorithm [23], and visual-
ized using Java Treeview [91]. The data files for each array
are publicly available at the Gene Expression Omnibus
(GEO) database repository http://www.ncbi.nlm.nih.gov/
geo/ (GSE 16803).
The GeneTrail software program [17,18] was used to iden-
tify Gene Ontology (GO) and Kyoto Encyclopedia of
Genes and Genomes (KEGG) categories enriched in spec-
ified subsets of the data [20,92].
Quantitative real time RT PCR
Differential gene expression identified by microarray
analysis was validated by determining the relative quanti-
ties of several gene transcripts from infected and unin-
fected mice using real time RT PCR. Several recent studies
have demonstrated that there is no one universal reference
gene that has constant, stable expression in all different
tissue types [93,94]. Thus, to identify an appropriate inter-BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
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nal control for these experiments, we evaluated the
expression of a set of commonly used control genes [94],
and identified ywhaz (Accession #NM_011740) as a gene
with low variance in expression across the entire sample
set, and no difference in expression in the control and
infected mice. PCR primers were designed and used for
qRT PCR on a panel of representative test samples from
both uninfected and infected mice. High Capacity cDNA
kit (Applied Biosystems, Foster City, CA, USA) was used to
generate first strand cDNA according to manufactures rec-
ommendations. Briefly, 2 μg of either Mouse Universal
Reference or at least 0.5 μg of Sample total RNA were used
as template for reverse Transcription. The reactions were
run in an MJ Research Tetrad Thermal Cycler tracking the
lid temperature (2°C above) as follows: 25°C/10 min;
37°C/120 min; 85°C/5 seconds. cDNA samples were
purified using Zymo-5 DNA clean up and concentration
kits (Zymo Research, Orange, CA). cDNA concentration
and purity were assessed using a Nanodrop. PCR reactions
were prepared using the Power SYBR Green PCR Master
Mix (Applied Biosystems). Amplifications were per-
formed on a AB 7300 real time machine under the follow-
ing conditions: 95°C/10 min; 95°C/15 seconds; 55°C/60
seconds; return to step 2 for 44 more times. Primers used
in this study are listed in Table 4.
Universal Mouse Reference RNA (Stratagene) spiked with
RNA known to contain Type I interferon messages was
used to establish a standard curve, which was highly
reproducible between assays (Pearson correlation coeffi-
cient >0.998 over a four-log (base 10) range). Relative
abundance of the target transcripts was calculated by com-
parison to the standard curve, and normalized to ywhaz
expression levels.
Confocal immunofluorescent microscopy
For immunofluorescence microscopy, samples were fixed
with 2% paraformaldehyde in 100 mM phosphate buffer
(pH 7.4) for 1 h, and were permeabilized in PBS 1%
saponin 3% bovine serum albumin. After incubation with
appropriate antibodies/probes, we mounted intact tissue
in Vectashield mounting medium (Vector Laboratories,
Burlingame, California, United States and imaged the
stained tissues without prior embedding and sectioning.
Samples were imaged with a confocal microscope (Bio-
Rad) by taking optical sections at 0.5-μm resolution. Fig-
ures were assembled with Photoshop software (Adobe,
San Jose, California, United States).
S. pneumoniae were detected by incubation of samples
with 1:500 dilution of polyclonal IgY antibodies
(chicken) (Aves Labs, Tigard, Oregon). Host cell DNA was
visualized using toto-3 (Molecular Probes). NALT tissue
contains mucus-producing goblet cells. To visualize
NALT, we used 1:300 dilution of the Ulex europeas Agglu-
tinin 1 (UEA 1) lectin, which preferentially binds to gob-
let cells. Anti-IgG 1:500 dilution of Alexa-fluor conjugated
chicken antibodies were used for secondary detection of
the anti-pneumococcal IgY (Molecular Probes).
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Table 4: Primers used in this study
Primer Name Sequence 5' → 3'
Ywhaz_F CACAGCCTCCCCTCATCCT
Ywhaz_R GGGAGACGGTGACAGACCAT
Socs3_F GCCACCTGGACTCCTATGAGAA
Socs3_R TCTGACCCTTTTGCTCCTTAAAGT
Ifit3_F GGGAGAATGTGCTGAAAAAAGC
Ifit3_R GGAGTCAGGGAGAGAAAGCAGTT
Irg1_F TTTTTCTTTCCACACAGAGCCTTA
Irg1_R ACTGCTTCACCACCCCAAGT
InfA2_F GTGAGGAAATACTTCCACAG
InfA2_R GGCTCTCCAGACTTCTGCTC
InfB2_F CAGCTCCAAGAAAGGACGAAC
InfB2_R GGCAGTGTAACTCTTCTGCAT
InfG_F GAACTGGCAAAAGGATGGTGA
InfG_R TGTGGGTTGTTGACCTCAAACBMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
Page 14 of 16
(page number not for citation purposes)
Acknowledgements
We are most grateful to Amy V Kapp for statistical advice, JL Sonnenberg, 
MR Amieva, T Henry, and DM Monack for critically reading the manuscript, 
and MRA for technical assistance with the confocal microscope. We thank 
Novartis Vaccine and Diagnostics, Inc. (Sienna, Italy) for providing financial 
support for this work.
References
1. Austrian R: Some aspects of the pneumococcal carrier state.
J Antimicrob Chemother 1986, 18(Suppl A):35-45.
2. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Rea-
sonover A, Hennessy TW: Indirect effect of conjugate vaccine
on adult carriage of Streptococcus pneumoniae: an explana-
tion of trends in invasive pneumococcal disease.  J Infect Dis
2006, 193:1487-1494.
3. Hill PC, Cheung YB, Akisanya A, Sankareh K, Lahai G, Greenwood
BM, Adegbola RA: Nasopharyngeal carriage of Streptococcus
pneumoniae in Gambian infants: a longitudinal study.  Clin
Infect Dis 2008, 46:807-814.
4. Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, Ekdahl K:
Age- and serogroup-related differences in observed dura-
tions of nasopharyngeal carriage of penicillin-resistant pneu-
mococci.  J Clin Microbiol 2007, 45:948-952.
5. McCool TL, Cate TR, Moy G, Weiser JN: The immune response
to pneumococcal proteins during experimental human car-
riage.  J Exp Med 2002, 195:359-365.
6. Zhang Q, Bernatoniene J, Bagrade L, Pollard AJ, Mitchell TJ, Paton JC,
Finn A: Serum and mucosal antibody responses to pneumo-
coccal protein antigens in children: relationships with car-
riage status.  Eur J Immunol 2006, 36:46-57.
7. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW,
Lipsitch M: CD4+ T cells mediate antibody-independent
acquired immunity to pneumococcal colonization.  Proc Natl
Acad Sci USA 2005, 102:4848-4853.
8. Trzcinski K, Thompson CM, Srivastava A, Basset A, Malley R, Lipsitch
M: Protection against nasopharyngeal colonization by Strep-
tococcus pneumoniae is mediated by antigen-specific CD4+
T cells.  Infect Immun 2008, 76:2678-2684.
9. van Rossum AM, Lysenko ES, Weiser JN: Host and bacterial fac-
tors contributing to the clearance of colonization by Strep-
tococcus pneumoniae in a murine model.  Infect Immun 2005,
73:7718-7726.
10. McCool TL, Weiser JN: Limited role of antibody in clearance of
Streptococcus pneumoniae in a murine model of coloniza-
tion.  Infect Immun 2004, 72:5807-5813.
11. Wu HY, Virolainen A, Mathews B, King J, Russell MW, Briles DE:
Establishment of a Streptococcus pneumoniae nasopharyn-
geal colonization model in adult mice.  Microb Pathog 1997,
23:127-137.
12. Asanuma H, Thompson AH, Iwasaki T, Sato Y, Inaba Y, Aizawa C,
Kurata T, Tamura S: Isolation and characterization of mouse
nasal-associated lymphoid tissue.  J Immunol Methods 1997,
202:123-131.
13. Wu HY, Nguyen HH, Russell MW: Nasal lymphoid tissue
(NALT) as a mucosal immune inductive site.  Scand J Immunol
1997, 46:506-513.
14. Zhang Q, Choo S, Finn A: Immune responses to novel pneumo-
coccal proteins pneumolysin, PspA, PsaA, and CbpA in ade-
noidal B cells from children.  Infect Immun 2002, 70:5363-5369.
15. Tusher VG, Tibshirani R, Chu G: Significance analysis of micro-
arrays applied to the ionizing radiation response.  Proc Natl
Acad Sci USA 2001, 98:5116-5121.
16. Conover WJ, Johnson ME, Johnson MM: A comparative study of
test for homogeneity of variances, with applications to teh
outer continental shelf bidding data.  Technometrics 1981,
23:351-361.
17. GeneTrail   [http://genetrail.bioinf.uni-sb.de/]
18. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, Elnakady YA,
Muller R, Meese E, Lenhof HP: GeneTrail – advanced gene set
enrichment analysis.  Nucleic Acids Res 2007, 35:W186-192.
19. Gene Ontology Consortium   [http://www.geneontology.org/]
20. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM,
Davis AP, Dolinski K, Dwight SS, Eppig JT, et al.: Gene ontology:
tool for the unification of biology. The Gene Ontology Con-
sortium.  Nat Genet 2000, 25:25-29.
21. Kyoto Encyclopedia of Genes and Genomes   [ h t t p : / /
www.genome.jp/kegg/]
22. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and
genomes.  Nucleic Acids Res 2000, 28:27-30.
23. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E,
Lander ES, Golub TR: Interpreting patterns of gene expression
with self-organizing maps: methods and application to
hematopoietic differentiation.  Proc Natl Acad Sci USA 1999,
96:2907-2912.
24. Boulnois GJ, Paton JC, Mitchell TJ, Andrew PW: Structure and
function of pneumolysin, the multifunctional, thiol-activated
toxin of Streptococcus pneumoniae.  Mol Microbiol 1991,
5:2611-2616.
25. Mitchell TJ, Andrew PW: Biological properties of pneumolysin.
Microb Drug Resist 1997, 3:19-26.
26. Paton JC: The contribution of pneumolysin to the pathogenic-
ity of Streptococcus pneumoniae.  Trends Microbiol 1996,
4:103-106.
27. Rubins JB, Janoff EN: Pneumolysin: a multifunctional pneumo-
coccal virulence factor.  J Lab Clin Med 1998, 131:21-27.
28. Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H,
Akira S, Normark S, Henriques-Normark B: Toll-like receptor 9
acts at an early stage in host defence against pneumococcal
infection.  Cell Microbiol 2007, 9:633-644.
29. Lee KS, Scanga CA, Bachelder EM, Chen Q, Snapper CM: TLR2 syn-
ergizes with both TLR4 and TLR9 for induction of the
MyD88-dependent splenic cytokine and chemokine response
to Streptococcus pneumoniae.  Cell Immunol 2007, 245:103-110.
30. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy
DA: Mice lacking the type I interferon receptor are resistant
to Listeria monocytogenes.  J Exp Med 2004, 200:527-533.
31. Devitt A, Lund PA, Morris AG, Pearce JH: Induction of alpha/beta
interferon and dependent nitric oxide synthesis during
Chlamydia trachomatis infection of McCoy cells in the
absence of exogenous cytokine.  Infect Immun 1996,
64:3951-3956.
32. Henry T, Brotcke A, Weiss DS, Thompson LJ, Monack DM: Type I
interferon signaling is required for activation of the inflam-
masome during Francisella infection.  J Exp Med 2007,
204:987-994.
33. Stetson DB, Medzhitov R: Recognition of cytosolic DNA acti-
vates an IRF3-dependent innate immune response.  Immunity
2006, 24:93-103.
34. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gel-
latly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE: The commen-
sal Streptococcus salivarius K12 downregulates the innate
immune responses of human epithelial cells and promotes
host-microbe homeostasis.  Infect Immun 2008, 76:4163-4175.
35. Munakata K, Yamamoto M, Anjiki N, Nishiyama M, Imamura S, Iizuka
S, Takashima K, Ishige A, Hioki K, Ohnishi Y, Watanabe K: Impor-
tance of the interferon-alpha system in murine large intes-
tine indicated by microarray analysis of commensal bacteria-
induced immunological changes.  BMC Genomics 2008, 9:192.
36. Charrel-Dennis M, Latz E, Halmen KA, Trieu-Cuot P, Fitzgerald KA,
Kasper DL, Golenbock DT: TLR-independent type I interferon
induction in response to an extracellular bacterial pathogen
via intracellular recognition of its DNA.  Cell Host Microbe 2008,
4:543-554.
37. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman
RH, Borden EC: Apoptosis and interferons: role of interferon-
Additional file 2
Gene List resulting from Variation analysis. List of gene symbols and 
description as well as the microarray oligo ID for genes whose expression 
varied most between infected and mock-infected mice over the entire time 
course.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-404-S2.txt]BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
Page 15 of 16
(page number not for citation purposes)
stimulated genes as mediators of apoptosis.  Apoptosis 2003,
8:237-249.
38. Yamamoto-Yamaguchi Y, Okabe-Kado J, Kasukabe T, Honma Y:
Induction of apoptosis by combined treatment with differen-
tiation-inducing agents and interferon-alpha in human lung
cancer cells.  Anticancer Res 2003, 23:2537-2547.
39. Bluyssen HA, Vlietstra RJ, Faber PW, Smit EM, Hagemeijer A, Trap-
man J: Structure, chromosome localization, and regulation of
expression of the interferon-regulated mouse Ifi54/Ifi56 gene
family.  Genomics 1994, 24:137-148.
40. Pol AN van den, Robek MD, Ghosh PK, Ozduman K, Bandi P, Whim
MD, Wollmann G: Cytomegalovirus induces interferon-stimu-
lated gene expression and is attenuated by interferon in the
developing brain.  J Virol 2007, 81:332-348.
41. Gribaudo G, Ravaglia S, Guandalini L, Riera L, Gariglio M, Landolfo S:
Molecular cloning and expression of an interferon-inducible
protein encoded by gene 203 from the gene 200 cluster.  Eur
J Biochem 1997, 249:258-264.
42. MacMicking JD: IFN-inducible GTPases and immunity to intra-
cellular pathogens.  Trends Immunol 2004, 25:601-609.
43. Klamp T, Boehm U, Schenk D, Pfeffer K, Howard JC: A giant
GTPase, very large inducible GTPase-1, is inducible by IFNs.
J Immunol 2003, 171:1255-1265.
44. Lagasse E, Clerc RG: Cloning and expression of two human
genes encoding calcium-binding proteins that are regulated
during myeloid differentiation.  Mol Cell Biol 1988, 8:2402-2410.
45. Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C: Com-
plex pattern of the myelo-monocytic differentiation antigens
MRP8 and MRP14 during chronic airway inflammation.
Immunobiology 1992, 186:304-314.
46. Zwadlo G, Bruggen J, Gerhards G, Schlegel R, Sorg C: Two calcium-
binding proteins associated with specific stages of myeloid
cell differentiation are expressed by subsets of macrophages
in inflammatory tissues.  Clin Exp Immunol 1988, 72:510-515.
47. Frosch M, Metze D, Foell D, Vogl T, Sorg C, Sunderkotter C, Roth J:
Early activation of cutaneous vessels and epithelial cells is
characteristic of acute systemic onset juvenile idiopathic
arthritis.  Exp Dermatol 2005, 14:259-265.
48. Lysenko ES, Ratner AJ, Nelson AL, Weiser JN: The role of innate
immune responses in the outcome of interspecies competi-
tion for colonization of mucosal surfaces.  PLoS Pathog 2005,
1:e1.
49. Ganz T: Defensins: antimicrobial peptides of innate immu-
nity.  Nat Rev Immunol 2003, 3:710-720.
50. Bouskra D, Brezillon C, Berard M, Werts C, Varona R, Boneca IG,
Eberl G: Lymphoid tissue genesis induced by commensals
through NOD1 regulates intestinal homeostasis.  Nature 2008,
456:507-510.
51. Kiyono H, Fukuyama S: NALT-versus Peyer's-patch-mediated
mucosal immunity.  Nat Rev Immunol 2004, 4:699-710.
52. Wiesemann E, Deb M, Trebst C, Hemmer B, Stangel M, Windhagen
A:  Effects of interferon-beta on co-signaling molecules:
upregulation of CD40, CD86 and PD-L2 on monocytes in
relation to clinical response to interferon-beta treatment in
patients with multiple sclerosis.  Mult Scler 2008, 14:166-176.
53. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH,
Freeman GJ, Ahmed R: Restoring function in exhausted CD8 T
cells during chronic viral infection.  Nature 2006, 439:682-687.
54. Weigent DA, Huff TL, Peterson JW, Stanton GJ, Baron S: Role of
interferon in streptococcal infection in the mouse.  Microb
Pathog 1986, 1:399-407.
55. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, Galbo R,
Tomasello F, Gambuzza M, Macri G, Ruggeri A, et al.: Type I IFN sig-
naling is crucial for host resistance against different species
of pathogenic bacteria.  J Immunol 2007, 178:3126-3133.
56. Rogers PD, Thornton J, Barker KS, McDaniel DO, Sacks GS, Swiatlo
E, McDaniel LS: Pneumolysin-dependent and -independent
gene expression identified by cDNA microarray analysis of
THP-1 human mononuclear cells stimulated by Streptococ-
cus pneumoniae.  Infect Immun 2003, 71:2087-2094.
57. Katz HR: Inhibition of pathologic inflammation by leukocyte
Ig-like receptor B4 and related inhibitory receptors.  Immunol
Rev 2007, 217:222-230.
58. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK,
Zurawski G, Moshrefi M, Qin J, Li X, et al.: IL-33, an interleukin-1-
like cytokine that signals via the IL-1 receptor-related pro-
tein ST2 and induces T helper type 2-associated cytokines.
Immunity 2005, 23:479-490.
59. Trajkovic V, Sweet MJ, Xu D: T1/ST2 – an IL-1 receptor-like
modulator of immune responses.  Cytokine Growth Factor Rev
2004, 15:87-95.
60. Turner M, Mee PJ, Walters AE, Quinn ME, Mellor AL, Zamoyska R,
Tybulewicz VL: A requirement for the Rho-family GTP
exchange factor Vav in positive and negative selection of thy-
mocytes.  Immunity 1997, 7:451-460.
61. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith
H, Shi X, Gonzalo JA, Newman W, et al.: Cloning of the human
eosinophil chemoattractant, eotaxin. Expression, receptor
binding, and functional properties suggest a mechanism for
the selective recruitment of eosinophils.  J Clin Invest 1996,
97:604-612.
62. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P: Tar-
geted disruption of the chemokine eotaxin partially reduces
antigen-induced tissue eosinophilia.  J Exp Med 1997,
185:785-790.
63. Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, Collins
PD, Williams TJ: Differential regulation of eosinophil chemok-
ine signaling via CCR3 and non-CCR3 pathways.  J Immunol
1999, 162:2946-2955.
64. Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG,
Walls AF, Askenase PW, Kay AB: C-C chemokines in allergen-
induced late-phase cutaneous responses in atopic subjects:
association of eotaxin with early 6-hour eosinophils, and of
eotaxin-2 and monocyte chemoattractant protein-4 with the
later 24-hour tissue eosinophilia, and relationship to
basophils and other C-C chemokines (monocyte chemoat-
tractant protein-3 and RANTES).  J Immunol 1999,
163:3976-3984.
65. Corriden R, Chen Y, Inoue Y, Beldi G, Robson SC, Insel PA, Junger
WG: Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-
NTPDase1/CD39) regulates neutrophil chemotaxis by
hydrolyzing released ATP to adenosine.  J Biol Chem 2008,
283:28480-28486.
66. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J,
Richmond A, Graham GJ, Segerer S, Nibbs RJ, Rot A: The Duffy
antigen receptor for chemokines transports chemokines and
supports their promigratory activity.  Nat Immunol 2009,
10:101-108.
67. Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN,
Skulsky E, Ho DD, Cheng-Mayer C, Marx PA: Normal T-cell turn-
over in sooty mangabeys harboring active simian immuno-
deficiency virus infection.  J Virol 2000, 74:1209-1223.
68. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell
cycle analysis of a cell proliferation-associated human
nuclear antigen defined by the monoclonal antibody Ki-67.  J
Immunol 1984, 133:1710-1715.
69. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC,
Axthelm MK, Picker LJ: Development and homeostasis of T cell
memory in rhesus macaque.  J Immunol 2002, 168:29-43.
70. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J,
Soden R, Hayakawa M, Kreiman G, et al.: A gene atlas of the
mouse and human protein-encoding transcriptomes.  Proc
Natl Acad Sci USA 2004, 101:6062-6067.
71. Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C,
Mathis D: Memory T and memory B cells share a transcrip-
tional program of self-renewal with long-term hematopoi-
etic stem cells.  Proc Natl Acad Sci USA 2006, 103:3304-3309.
72. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wag-
ner RA, Greaves DR, Murray PJ, Chawla A: Oxidative metabolism
and PGC-1beta attenuate macrophage-mediated inflamma-
tion.  Cell Metab 2006, 4:13-24.
73. Costalonga M, Cleary PP, Fischer LA, Zhao Z: Intranasal bacteria
induce Th1 but not Treg or Th2.  Mucosal Immunol 2009, 2:85-95.
74. Bootsma HJ, Egmont-Petersen M, Hermans PW: Analysis of the in
vitro transcriptional response of human pharyngeal epithe-
lial cells to adherent Streptococcus pneumoniae: evidence
for a distinct response to encapsulated strains.  Infect Immun
2007, 75:5489-5499.
75. Hava DL, Camilli A: Large-scale identification of serotype 4
Streptococcus pneumoniae virulence factors.  Mol Microbiol
2002, 45:1389-1406.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2009, 10:404 http://www.biomedcentral.com/1471-2164/10/404
Page 16 of 16
(page number not for citation purposes)
76. Hendriksen WT, Bootsma HJ, Estevao S, Hoogenboezem T, de Jong
A, de Groot R, Kuipers OP, Hermans PW: CodY of Streptococcus
pneumoniae: link between nutritional gene regulation and
colonization.  J Bacteriol 2008, 190:590-601.
77. Iyer R, Camilli A: Sucrose metabolism contributes to in vivo fit-
ness of Streptococcus pneumoniae.  Mol Microbiol 2007, 66:1-13.
78. Kowalko JE, Sebert ME: The Streptococcus pneumoniae com-
petence regulatory system influences respiratory tract colo-
nization.  Infect Immun 2008, 76:3131-3140.
79. Rosenow C, Ryan P, Weiser JN, Johnson S, Fontan P, Ortqvist A, Mas-
ure HR: Contribution of novel choline-binding proteins to
adherence, colonization and immunogenicity of Streptococ-
cus pneumoniae.  Mol Microbiol 1997, 25:819-829.
80. Sebert ME, Palmer LM, Rosenberg M, Weiser JN: Microarray-based
identification of htrA, a Streptococcus pneumoniae gene
that is regulated by the CiaRH two-component system and
contributes to nasopharyngeal colonization.  Infect Immun
2002, 70:4059-4067.
81. Song XM, Connor W, Hokamp K, Babiuk LA, Potter AA: Strepto-
coccus pneumoniae early response genes to human lung epi-
thelial cells.  BMC Res Notes 2008, 1:64.
82. Feldman C, Mitchell TJ, Andrew PW, Boulnois GJ, Read RC, Todd
HC, Cole PJ, Wilson R: The effect of Streptococcus pneumo-
niae pneumolysin on human respiratory epithelium in vitro.
Microb Pathog 1990, 9:275-284.
83. Rayner CF, Jackson AD, Rutman A, Dewar A, Mitchell TJ, Andrew
PW, Cole PJ, Wilson R: Interaction of pneumolysin-sufficient
and -deficient isogenic variants of Streptococcus pneumo-
niae with human respiratory mucosa.  Infect Immun 1995,
63:442-447.
84. Steinfort C, Wilson R, Mitchell T, Feldman C, Rutman A, Todd H,
Sykes D, Walker J, Saunders K, Andrew PW, et al.: Effect of Strep-
tococcus pneumoniae on human respiratory epithelium in
vitro.  Infect Immun 1989, 57:2006-2013.
85. McCool TL, Cate TR, Tuomanen EI, Adrian P, Mitchell TJ, Weiser JN:
Serum immunoglobulin G response to candidate vaccine
antigens during experimental human pneumococcal coloni-
zation.  Infect Immun 2003, 71:5724-5732.
86. Nelson AL, Barasch JM, Bunte RM, Weiser JN: Bacterial coloniza-
tion of nasal mucosa induces expression of siderocalin, an
iron-sequestering component of innate immunity.  Cell Micro-
biol 2005, 7:1404-1417.
87. Joyce EA, Kawale A, Censini S, Kim CC, Covacci A, Falkow S: LuxS
is required for persistent pneumococcal carriage and
expression of virulence and biosynthesis genes.  Infect Immun
2004, 72:2964-2975.
88. Alizahdeh Lab   [http://alizadehlab.stanford.edu/]
89. Stanford Microarray Database   [http://genome-www5.stan
ford.edu/]
90. Gene Expression Omnibus   [http://www.ncbi.nlm.nih.gov/geo/]
91. Saldanha AJ: Java Treeview – extensible visualization of micro-
array data.  Bioinformatics 2004, 20:3246-3248.
92. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M,
Kawashima S, Katayama T, Araki M, Hirakawa M: From genomics
to chemical genomics: new developments in KEGG.  Nucleic
Acids Res 2006, 34:D354-357.
93. Ayers D, Clements DN, Salway F, Day PJ: Expression stability of
commonly used reference genes in canine articular connec-
tive tissues.  BMC Vet Res 2007, 3:7.
94. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
Paepe A, Speleman F: Accurate normalization of real-time
quantitative RT-PCR data by geometric averaging of multi-
ple internal control genes.  Genome Biol 2002, 3:RESEARCH0034.